XML 63 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail) - USD ($)
3 Months Ended
Sep. 24, 2022
Mar. 26, 2022
Sep. 25, 2021
Dec. 26, 2020
Dec. 28, 2019
Dec. 25, 2021
Jun. 26, 2021
Mar. 27, 2021
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value $ 5,518,200,000   $ 5,578,100,000          
Accumulated Amortization 4,237,600,000   3,918,900,000          
Impairment charge     1,800,000 $ 30,200,000 $ 30,200,000      
Developed technology                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 4,565,600,000   4,597,700,000          
Accumulated Amortization 3,458,200,000   3,184,200,000          
In Process Research and Development [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 33,000,000.0   71,600,000          
Accumulated Amortization 0   0          
Customer relationships                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 601,900,000   591,700,000          
Accumulated Amortization 535,600,000   510,100,000          
Trade Names [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 265,200,000   268,100,000          
Accumulated Amortization 203,300,000   191,800,000          
Acquired intangible assets [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 5,465,700,000   5,529,100,000          
Accumulated Amortization 4,197,100,000   3,886,100,000          
Internal-use software [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 26,000,000.0   23,500,000          
Accumulated Amortization 19,900,000   17,200,000          
Capitalized software [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 26,500,000   25,500,000          
Accumulated Amortization 20,600,000   $ 15,600,000          
Mobidiag Oy | In Process Research and Development [Member]                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill             $ 74,000,000  
Mobidiag Oy | Trade Names [Member]                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill             20,000,000  
Mobidiag Oy | Customer Relationships                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill             20,900,000  
Mobidiag Oy | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge $ 27,700,000              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill             $ 285,000,000  
Biotheranostics | Trade Names [Member]                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               $ 2,100,000
Biotheranostics | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               160,300,000
Diagenode | Customer Relationships                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               9,200,000
Diagenode | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               69,800,000
Somatex | Customer relationships                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               1,200,000
Somatex | Trade Names [Member]                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               900,000
Somatex | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill               $ 38,000,000
Faxitron | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge   $ 9,200,000            
Bolder Surgical | Trade Names [Member]                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill           $ 1,400,000    
Bolder Surgical | Customer Relationships                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill           21,700,000    
Bolder Surgical | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill           $ 73,600,000    
Focal Therapeutics | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge   $ 8,200,000